News and Trends 27 Sep 2022
Protocol for treatment of neurotrophic keratopathy submitted to FDA by ReGenTree
Protocol for a second phase 3 clinical trial for a treatment for neurotrophic keratopathy (NK) - a degenerative disease of the corneal epithelium resulting from impaired corneal innervation, has been…